Molecular Diagnostics
Novel Tool Developed to Detect and Identify Pathogens
Pathogens in clinical or wildlife settings samples of blood or saliva, for example, are particularly challenging to isolate, since they can easily make up less than one one-millionth of a sample, especially in early stages of an infection, when concentrations are still low and detection is most critical for patients. More...28 Sep 2021
Placental MicroRNAs Diagnosis Pregnancy Progress and Fetal Distress
Analysis of placental microRNAs (miRNAs), which also circulate in the maternal blood, represents a significant improvement to currently used pregnancy screening tools, allowing assessment of placental health, and therefore fetal health, in real time. More...28 Sep 2021
Thermo Fisher Presents Newest LC-MS/MS Instrumentation and Latest Innovations in Molecular Diagnostics
Thermo Fisher Scientific Inc. (Waltham, MA; USA) presented its newest LC-MS/MS instrumentation and latest innovations in molecular diagnostics at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo held at the Georgia World Congress Center in Atlanta, September 26-30. More...28 Sep 2021
Clear Labs Introduces Clear Dx SARS-CoV-2 Solution That Addresses and Overcomes Traditional Barriers to NGS
Clear Labs (San Carlos, CA, USA) introduced its new Clear Dx SARS-CoV-2 solution that addresses and overcomes traditional barriers to next-generation sequencing (NGS) at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo which explored the cutting-edge science and technology shaping the future of laboratory medicine. More...28 Sep 2021
Randox Showcases Pioneering Diagnostic Technologies at 2021 AACC Clinical Lab Expo
Randox Laboratories (Crumlin, UK) showcased its pioneering diagnostic technologies at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, which saw breakthrough innovations shaping the future of clinical testing and patient care. More...28 Sep 2021
Automated Detection of Arm-Level Alterations for Individual Cancer Patients
Copy number alterations (CNAs) can be gains, losses, or loss of heterozygosity (LOH) of a chromosome segment. Based on the length of the altered segment, they are crudely classified as “focal alterations” and “arm-level alterations”. More...25 Sep 2021
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Steam Sterilizer
Hi Vac II Line
New
Manual Pipetting Aid
Pipette Controllers macro
In Other News
Serum Levels of Thymidine Kinase Predict Disease Progression and Overall Survival of Metastatic Breast Cancer Patients
Certest Offers Real-Time PCR Assays for Fast Detection of MDR Bacterial Infections
Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System
Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System
Metabolic Biomarker Panel Shows Promise for Diagnosis of Dementia
Acute Lymphoblastic Leukemia Risk Linked to Genetically Mediated Increase in Lymphocytes
Biomarkers Found for COVID-19 MIS-C Condition in Children
Blood Biomarkers Predict Likelihood of Castleman Disease Treatment Response
Liquid Biopsy Assay Evaluated for Early Detection of Gastric Cancer
Genomics Approach Links ABO Blood Type to Inflammatory and Cardiovascular Diseases
Immune Cell Biomarker Predicts Response to Treatment with Checkpoint Inhibitor Drugs
Novel PCR Test Could Quickly Distinguish Breast Cancer from Benign Tumors
Molecular Characterization of Microbiota in Cerebrospinal Fluid Using WGA
Donor-Linked Biomarker Predicts Likelihood of Liver Transplant Success
Leptomeningeal Disease Diagnosed Using CSF Cell-Free DNA
Various Serum Vitamin D Biomarkers Compared for Sarcopenia
Sphingolipids Are Prognostic Biomarkers for African American SLE Patients with Cardiovascular Disease
CSF biomarkers Compared for Down Syndrome and Inherited Alzheimer’s
More Complete Genetic Screening Benefits Cardiovascular Disease Patients
A Novel Liquid Biopsy Spectroscopy Method for Early Detection of Brain Tumors
A Circulating Adipokine Is a Possible Biomarker for Severity of Systemic Sclerosis-Associated Interstitial Lung Disease
Lipid Metabolism Affects GBA-Associated Parkinson's Disease
Genomes of Advanced Neuroendocrine Neoplasms Unveil Subtypes
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.